Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Undetectable MRD and Extended PFS More Common with MRD-guided Ibrutinib-Venetoclax than...

Ogkologos - 13 Οκτωβρίου, 2025

ESMO’s Special Consultative Status with United Nations Economic and Social Council...

Ogkologos - 10 Οκτωβρίου, 2025

FDA Approves Imlunestrant for ER-positive, HER2-negative, ESR1-mutated Advanced or Metastatic Breast...

Ogkologos - 10 Οκτωβρίου, 2025

EMA Recommends Extension of Indications for Selumetinib

Ogkologos - 9 Οκτωβρίου, 2025

ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical...

Ogkologos - 8 Οκτωβρίου, 2025

Exploratory 4-year Analysis Continues to Support Adding 3 Years of Ribociclib...

Ogkologos - 8 Οκτωβρίου, 2025

How you can do your part in the AI transformation of...

Ogkologos - 7 Οκτωβρίου, 2025

Increased Risk of Haematologic Malignancies Among Children and Adolescents Exposed to...

Ogkologos - 7 Οκτωβρίου, 2025

ESMO Welcomes New Cancer Focused UN Political Declaration on Non-Communicable Diseases

Ogkologos - 6 Οκτωβρίου, 2025

EMA Recommends Extending Indications for Pembrolizumab and Adopted a New Pharmaceutical...

Ogkologos - 3 Οκτωβρίου, 2025

1...363738...440 Σελίδα 37 από 440

MOST POPULAR

Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with...

9 Απριλίου, 2026

Radionuclide Therapy Could Be A Viable Treatment For Early-Stage Breast Cancer,...

20 Φεβρουαρίου, 2020

EMA Recommends Granting a Marketing Authorisation for Celdoxome Pegylated Liposomal

1 Σεπτεμβρίου, 2022

Exploring Coping Resources to Help with Physical, Practical, and Emotional Challenges...

8 Ιανουαρίου, 2024

Φόρτωση περισσοτέρων

Undetectable MRD and Extended PFS More Common with MRD-guided Ibrutinib-Venetoclax than...

ESMO’s Special Consultative Status with United Nations Economic and Social Council...

FDA Approves Imlunestrant for ER-positive, HER2-negative, ESR1-mutated Advanced or Metastatic Breast...

EMA Recommends Extension of Indications for Selumetinib

ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical...

Exploratory 4-year Analysis Continues to Support Adding 3 Years of Ribociclib...

How you can do your part in the AI transformation of...

Increased Risk of Haematologic Malignancies Among Children and Adolescents Exposed to...

ESMO Welcomes New Cancer Focused UN Political Declaration on Non-Communicable Diseases

EMA Recommends Extending Indications for Pembrolizumab and Adopted a New Pharmaceutical...

MOST POPULAR

Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with...

Radionuclide Therapy Could Be A Viable Treatment For Early-Stage Breast Cancer,...

EMA Recommends Granting a Marketing Authorisation for Celdoxome Pegylated Liposomal

Exploring Coping Resources to Help with Physical, Practical, and Emotional Challenges...

HOT NEWS

Concurrent Chemoradiotherapy Followed by Adjuvant Cisplatin-Gemcitabine for the Treatment of Patients...

Is there a right way to check your body for cancer?

5-Year-Old Boy Battling Cancer Receives Dream Come True, Sworn In As...

Moxetumomab Approved by FDA for Hairy Cell Leukemia

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ